ESIS launches healthcare industry risk management practice

ESIS, Inc., Chubb’s risk management services division, has launched a new industry practice dedicated to serving the claims and risk management needs of healthcare organizations and life sciences firms, reports Insurance Journal.

The new ESIS Healthcare Industry Practice, offering insurance products and services for healthcare customers, will include a range of claims and risk management services tailored to hospitals, senior care facilities, physician groups, ancillary healthcare organizations and manufacturers.

As well as providing self-insured organizations, risk retention groups, other alternative markets and insurance companies with specialized claim management services such as healthcare professional liability claim management, litigation management, medical record reviews, investigations, clinical risk management consultation, National Practitioners Data Bank reporting, MMSEA reporting, and claim capability and reserve auditing.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.